Table 1 (abstract P051). Clinical, laboratory, and treatment characteristics
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Variable | JIA basal n=52 | JIA V24 n=52 | p-value |
|---|---|---|---|
Age in years, mean (±SD) | 22.8 (5.1) | 25.0 (6.1) | <0.001 |
Sex, woman, n (%) | 35 (67.3) | 35 (67.3) | 1.000 |
Evolution time JIA, months, median (IQR) | 134.1 (95.6-214.2) | 161.4 (103.6-220.4) | <0.001 |
Oligoarticular JIA, n (%) | 30 (57.7) | 30 (57.7) | 1.000 |
Depression with BDI-II, n (%) | 8 (15,4) | 13 (25) | 0.046 |
CRP average, median (IQR) | - | 3.4 (2.9-4.2) | - |
JADAS27 average, median (IQR) | - | 4.0 (2.8-9.2) | - |
Synthetic DMARDs, n (%) | 24 (46.2) | 22 (42.3) | 0.785 |
Biological DMARDs, n (%) | 28 (53.8) | 31 (59.6) | 0.182 |